Coronary artery bypass surgery is superior to second generation drug-eluting stents in three-vessel coronary artery disease: a propensity score matched analysis.

@article{Tsuneyoshi2017CoronaryAB,
  title={Coronary artery bypass surgery is superior to second generation drug-eluting stents in three-vessel coronary artery disease: a propensity score matched analysis.},
  author={Hiroshi Tsuneyoshi and Tatsuhiko Komiya and Kazushige Kadota and Takeshi Shimamoto and Jiro Sakai and Toshifumi Hiraoka and Kenji Wada and Hiroyuki Kaneko and Yuka Fujimoto and Yoshimasa Furuichi and Reo Hata and Taiyo Jinno and Osamu Tominaga},
  journal={European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery},
  year={2017},
  volume={52 3},
  pages={
          462-468
        }
}
OBJECTIVES Compared with percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG) appears to be a promising revascularization strategy for multivessel coronary disease. Trials comparing these treatments have not used second-generation drug-eluting stents (2nd DES). We conducted a retrospective evaluation of both treatments using a propensity score-matched analysis (PSMA). METHODS A total of 537 patients with three-vessel with/without left-main-trunk coronary artery… CONTINUE READING